Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational ...

The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development arm of Scripps Research, today announced two milestones in the clinical advancement of CLF065, its potential ...

The treatment for ulcerative colitis and Crohn’s disease combines two already available drugs that worked better in clinical trials than either drug alone, researchers report.

Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease. This ...

A handful of cancer cases reported among treatment recipients overshadowed efficacy results analysts described as ...

A nurse-patient ‘mutuality’ shows a positive association with self-care behaviors in adults with inflammatory bowel disease.

For the estimated 5 million people worldwide living with inflammatory bowel disease, finding relief from debilitating symptoms often feels like an endless journey through medication trials and ...

Patients with inflammatory bowel disease often have to wait a long time to find the right medicine. But the methods of a large interdisciplinary research team offer hope. IBD is the common ...

Managing your healthcare can get more complicated as you age, especially with inflammatory bowel disease. Here’s what experts ...

TORONTO — Contrary to popular opinion — and some guidelines — nonsteroidal anti-inflammatory drugs (NSAIDs) may not always be contraindicated in patients with axial spondyloarthritis (axSpA) who have ...

​​Patients with IBD commonly experience persistent diarrhea, blood in stools, abdominal pain, weight loss, fatigue, and loss ...

For women with inflammatory bowel disease (IBD), pregnancy is already high-stakes -- and conflicting medical advice worldwide has only added to the uncertainty. Now, a global team of specialists and ...